IDENTIFICATION OF PATIENTS FOR BREAST CANCER THERAPHY USING T128 FAMILY MEMBERS AS MARKERS

The invention provides a method of detecting or monitoring breast cancer in a subject, or identifying the prognosis of a subject with breast cancer, comprising determining the level of and/or position of expression of a T128 family member, in a sample of tissue from the subject. Assay kits and metho...

Full description

Saved in:
Bibliographic Details
Main Authors REES, ROBERT CHARLES, MILES, AMANDA KATHLEEN, ABDEL-FATAH, TAREK MOHAMED AHMED, CHAN, STEPHEN YAN TAT
Format Patent
LanguageEnglish
French
Published 17.07.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

More Information
Summary:The invention provides a method of detecting or monitoring breast cancer in a subject, or identifying the prognosis of a subject with breast cancer, comprising determining the level of and/or position of expression of a T128 family member, in a sample of tissue from the subject. Assay kits and methods of treating patients are also provided. L'invention concerne un procédé de détection ou de surveillance de cancer du sein chez un sujet, ou d'identification du pronostic d'un sujet ayant un cancer du sein, comprenant la détermination du niveau et/ou de la position d'expression d'un élément de la famille T128 dans un échantillon de tissu du sujet. L'invention concerne également des kits de dosage et des procédés de traitement de patients.
Bibliography:Application Number: WO2014GB50090